about
The complete blood cell count in a refined cohort of preterm NEC: the importance of gestational age and day of diagnosis when using the CBC to estimate mortality.Transition from fetus to newborn.Recognition and reporting of AKI in very low birth weight infantsBladder wall necrosis in an extremely low-birth-weight infant: a thought-provoking complication of necrotizing enterocolitis.Necrotizing enterocolitis is one disease with many origins and potential means of prevention.Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones.Ileal Immunoglobulin Binding by the Neonatal Fc Receptor: A Previously Unrecognized Mechanism of Protection in the Neonatal Rat Model of Necrotizing Enterocolitis?Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosusDiagnosing intestinal perforation: a new approach.Nephrotoxic medication exposure in very low birth weight infants.Early births and congenital birth defects: a complex interaction.Abnormal heart rate characteristics are associated with abnormal neuroimaging and outcomes in extremely low birth weight infants.Can a national dataset generate a nomogram for necrotizing enterocolitis onset?Risk Factors for Invasive Fungal Infection in Premature Infants: Enhancing a Targeted Prevention Approach.NICU redesign from open ward to private room: a longitudinal study of parent and staff perceptions.A simple step to reduce radiation exposure in the NICU.Surgical necrotizing enterocolitis defined.Necrotizing enterocolitis: is it time for zero tolerance?Potential confounder of NEC clinical trialsAntenatal indomethacin is more likely associated with spontaneous intestinal perforation rather than NEC
P50
Q30278350-0D333CBD-316B-49D2-A9B8-26E84C9DAC09Q30300251-23F9D32F-708A-490A-B24E-A7BD5742A541Q30303164-64D0399C-3A00-42EC-B636-CAF910542CD5Q30312142-B607508C-5A35-4BFC-8D77-0C38C8E63973Q30357254-138D230C-F56C-4F29-A550-B0899A42867CQ30393832-B7D945B9-BD5D-49F3-9222-246E1AB30902Q30411401-8858EC2D-E0B5-4CCD-B742-5A13AD4FA66FQ30411583-79497DF4-1435-4033-990A-4394FEF9F918Q30446092-F95035EC-607D-4526-8E34-59A92F65A8F7Q30457095-BB8844FE-CC87-479F-8A14-E4A4AC12B635Q30457107-E3AFBF80-6D87-4348-B532-3BAF303B9541Q30457476-3AE17976-AC63-41E2-AC13-32CA543994E2Q30458771-5B3F1231-DD4E-434C-BC7A-D20BEE796CEEQ30459900-983F8772-60C6-4AF4-A90C-D133121352C9Q44981938-2A22FAF7-C965-46F6-A1AF-3E30E73E27FBQ44997339-17FAD85A-E7AD-4945-9C9E-554149CF47DBQ45003815-B172E274-8944-42A8-B887-B60598069C82Q48239335-D53F6B5D-6226-465F-90A3-9298BDEFE3ADQ59173710-556D6D58-8318-474C-8674-42BE49F97E4EQ59173712-1C2478F7-641A-4A4F-A4C8-4E5117CFD2E5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jonathan R Swanson
@ast
Jonathan R Swanson
@en
Jonathan R Swanson
@es
Jonathan R Swanson
@nl
type
label
Jonathan R Swanson
@ast
Jonathan R Swanson
@en
Jonathan R Swanson
@es
Jonathan R Swanson
@nl
prefLabel
Jonathan R Swanson
@ast
Jonathan R Swanson
@en
Jonathan R Swanson
@es
Jonathan R Swanson
@nl
P1053
P-3637-2015
P106
P21
P31
P3829
P496
0000-0002-9446-9306